Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Saint-Cloud, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
FranceStudy on the Effectiveness and Safety of Navepegritide for Adolescents with Achondroplasia
FranceStudy on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
FranceStudy on the Safety and Effectiveness of Acasunlimab and Pembrolizumab for Patients with Recurrent Non-Small Cell Lung Cancer
FranceStudy on Masitinib for Patients with Severe Mast Cell Activation Syndrome Unresponsive to Treatment
FranceStudy on Long-Acting Cabotegravir and Lenacapavir for HIV Patients: Evaluating Dual Antiretroviral Therapy
FranceStudy on Stopping or Continuing Anastrozole, Letrozole, and Exemestane for Patients with Advanced or Metastatic Low-Grade Endometrial Stromal Sarcoma
FranceStudy on the Safety and Effects of Berotralstat for Children Aged 2 to 12 with Hereditary Angioedema (HAE)
FranceStudy on [68Ga]Ga-PentixaFor for Staging and Evaluation in Symptomatic Multiple Myeloma Patients in Initial Treatment or Relapse
FranceStudy of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease
FranceStudy on the Safety and Effectiveness of Brexucabtagene Autoleucel for Children and Teens with Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
FranceStudy on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma and multiple myeloma treatments, including studies of novel therapies like duvelisib for T-cell lymphoma and odronextamab for follicular lymphoma.
Several studies are evaluating combination therapies and comparing new treatment approaches against standard care.
Comprehensive research into various types of breast cancer, with particular focus on hormone receptor-positive and triple-negative variants. Studies include early detection methods and novel therapeutic combinations.
Trials incorporate innovative approaches like ctDNA monitoring and targeted therapies.
Research focusing on targeted therapies for various advanced cancers, including studies of biliary tract cancer and non-small cell lung cancer treatments.
Emphasis on immunotherapy combinations and precision medicine approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
